Skip to main content
SpringerLink
Log in

Acetyl-L-carnitine for symptomatic diabetic neuropathy

  • Letters to the Editors
  • Published:
Diabetologia Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Young MJ, Boulton AJM, Macleod AF, Williams DRR, Sonksen PH (1993) A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 36: 150–154

    CAS  PubMed  Google Scholar 

  2. Malone JI, Lowitt S, Corsico N, Orfalian Z (1992) Altered neuroexcitability in experimental diabetic neuropathy: effect of acetyl-L-carnitine. Int J Clin Pharm Res 12: 237–241

    CAS  Google Scholar 

  3. Merry AC, Kamijo M, Lattimer SA, Ristic H, Sima AAF (1994) Long term prevention and intervention effects of acetyl-L-carnitine on diabetic neuropathy. Diabetes 43 [Suppl 1]: 108A (Abstract)

    Google Scholar 

  4. Stevens M, Lattimer SA, Feldman E (1994) Protective effects of Acetyl-L-carnitine on ketogenesis and sciatic nerve function in the streptozotocin diabetic rat. Diabetes 43 [Suppl 1]: 17A (Abstract)

    Google Scholar 

  5. Sass RL, Wermess P (1973) Acetylcarnitine: on the relationship between structure and function. Biochem Biophys Res Commun 55: 736–742

    Article  CAS  PubMed  Google Scholar 

  6. Martignoni E, Facchinetti F, Sances G et al. (1988) Acetyl-L-carnitine acutely administered raises beta-endorphin and cortisol plasma levels in humans. Clin Neuropharm 11: 472–477

    CAS  Google Scholar 

  7. Gorio A, Di Giulio AM, Tenconi B et al. (1992) Peptide alterations in autonomic diabetic neuropathy prevented by acetyl-L-carnitine. Int J Clin Pharm Res 12: 225–230

    CAS  Google Scholar 

  8. Tesco G, Latorraca S, Piersanti P et al. (1992) Protection from oxygen radical damage in human diploid fibroblasts by acetyl-L-carnitine. Dementia 3: 58–60

    Google Scholar 

  9. Cameron NE, Cotter MA, Archibald V, Dines KC, Maxfield EK (1994) Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats. Diabetologia 37: 449–459

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gerontology and Metabolic Diseases, Second University of Naples, Naples, Italy

    A. Quatraro

Authors
  1. A. Quatraro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Roca
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Donzella
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Acampora
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Marfella
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D. Giugliano
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Quatraro, A., Roca, P., Donzella, C. et al. Acetyl-L-carnitine for symptomatic diabetic neuropathy. Diabetologia 38, 123 (1995). https://doi.org/10.1007/BF02369363

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02369363

Keywords

Search

Navigation